Silexion Therapeutics* (NASDAQ: SLXN) is making strides in oncology with its RNAi-based treatment, SIL-204, targeting KRAS-driven cancers. In an interview on Market Leaders, CEO Ilan Hadar discussed the company’s recent…
Posts published in “Market Leaders”
Beyond Oil* (CSE: BOIL) (OTCQB: BEOLF), an innovative food-tech company, announced a transformative 5 year distribution agreement with Latitude with expected revenues of US$8.3 million in 2025 alone. Latitude the…